Approval · Notice of Compliance 23334 · 2020
FERRIPROX: Notice of Compliance 23334
Issued March 12, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23334
- Date
- March 12, 2020
- Company
- Chiesi Canada Corp.Woodbridge, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative: Change in Product Ownership
Products in this notice
Medicinal ingredients
- DEFERIPRONE 500 MG per TAB
- DEFERIPRONE 1,000 MG per TAB
- DEFERIPRONE 100 MG per ML